Assessing chemotherapy-induced peripheral neuropathy with patient reported outcome measures: a systematic review of measurement properties and considerations …

T Li, SB Park, E Battaglini, MT King, MC Kiernan… - Quality of Life …, 2022 - Springer
Purpose Chemotherapy-induced peripheral neuropathy (CIPN) is a common toxicity of
cancer treatment, with potential to significantly impact cancer survivors' long-term quality of …

[HTML][HTML] Peripheral neuropathy: A neglected cause of disability in COPD–A narrative review

I Odajiu, S Covantsev, P Sivapalan… - Respiratory …, 2022 - Elsevier
Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory syndrome with
systemic involvement leading to various cardiovascular, metabolic, and neurological …

Cancer‐related impairments and functional limitations among long‐term cancer survivors: gaps and opportunities for clinical practice

L Nekhlyudov, GB Campbell, KH Schmitz, GA Brooks… - Cancer, 2022 - Wiley Online Library
This commentary provides a concise overview of the epidemiology of cancer survivorship
and work, common functional limitations experienced by cancer survivors, and evidence …

Validity of patient-reported outcome measures in evaluating nerve damage following chemotherapy

T Li, HC Timmins, FM Mahfouz, T Trinh… - JAMA network …, 2024 - jamanetwork.com
Importance Chemotherapy-induced peripheral neuropathy (CIPN) is a substantial adverse
effect of anticancer treatments. As such, the assessment of CIPN remains critically important …

Prospective evaluation of health care provider and patient assessments in chemotherapy-induced peripheral neurotoxicity

P Alberti, DP Bernasconi, DR Cornblath, ISJ Merkies… - Neurology, 2021 - AAN Enterprises
Background and Objective There is no agreement on the gold standard for detection and
grading of chemotherapy-induced peripheral neurotoxicity (CIPN) in clinical trials. The …

Association of chemotherapy-induced peripheral neuropathy with diet quality among post-treatment cancer survivors

R Knoerl, R Ploutz-Snyder, L Smener… - Nutrition and …, 2024 - Taylor & Francis
Nutrition is essential for peripheral nerve function, yet dietary factors associated with chronic
chemotherapy-induced peripheral neuropathy (CIPN) remain poorly characterized. The …

Chemotherapy-induced peripheral neuropathy in newly diagnosed breast cancer survivors treated with taxane: a prospective longitudinal study

YJ Wang, YN Chan, YW Jheng, CJ Wu, MW Lin… - Supportive Care in …, 2021 - Springer
Purpose This study aimed to prospectively explore severity and prevalence of chemotherapy-
induced peripheral neuropathy (CIPN) and examine the correlation between clinician …

Preventing taxane-related peripheral neuropathy, pain and nail toxicity: a prospective self-controlled trial comparing hilotherapy with frozen gloves in early breast …

A Coolbrandt, K Vancoille, E Dejaeger… - Breast Cancer Research …, 2022 - Springer
Purpose The prevention of taxane-related toxicities at the extremities is highly important for
patients' treatment and quality-of-life. Several studies endorse hand/foot-cooling using …

Proactive rehabilitation for chemotherapy-induced peripheral neuropathy

R Knoerl, L Gilchrist, GA Kanzawa-Lee… - Seminars in Oncology …, 2020 - Elsevier
Objective To review assessment and management approaches for chemotherapy-induced
peripheral neuropathy-related physical function deficits. Data Sources Peer-reviewed …

Evaluation of the effect of pentoxifylline on the prevention of paclitaxel‑induced peripheral neuropathy in breast cancer patients: a randomized controlled study

SS Saleh, DEM Sherif, NA Sabri, MA Shawki - Future Journal of …, 2024 - Springer
Background Paclitaxel-induced peripheral neuropathy (PIPN) is one of the most common
and debilitating toxicity. Up till now, no treatment or preventive medication is recommended …